Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.
about
Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.The future of immune checkpoint blockade immunotherapy: towards personalized therapy or towards combination therapy.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesThe Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
P2860
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Genetic engineering of human N ...... ation to renal cell carcinoma.
@en
type
label
Genetic engineering of human N ...... ation to renal cell carcinoma.
@en
prefLabel
Genetic engineering of human N ...... ation to renal cell carcinoma.
@en
P2093
P2860
P1476
Genetic engineering of human N ...... ation to renal cell carcinoma.
@en
P2093
Ann-Helén Scherman-Plogell
Annet Duivenvoorden
Christina Seitz
Erik Wennerberg
Eugenia Colón
Maarten Ligtenberg
Rosa Zendehdel
Veronika Kremer
P2860
P2888
P356
10.1186/S40425-017-0275-9
P577
2017-09-19T00:00:00Z